BLLN

BillionToOne, Inc.

BillionToOne, Inc. (BLLN) has 20 SEC Form 4 filings (133 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 15, 2026.

The most active filer is SVP of Laboratory Operations ten Bosch John Roderick with 3 filings. Insiders have net sold $18.0M over the trailing 6 months.

  • Industry:Medical - Diagnostics & Research
  • CEO:Oguzhan Atay
  • Employees:620
  • HQ:Menlo Park, CA, US
  • IPO:2025-11-06

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$18.0M

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Market Cap

$6.6B

latest known value

Source
Sale$2.5MJul 15SEC ↗
Sale$178KJul 15SEC ↗
Sale$1.6MJul 13SEC ↗
Sale$1.0MJul 13SEC ↗
Sale$4.4MJul 8SEC ↗
Sale$100KJul 7SEC ↗
Sale$170KJul 1SEC ↗
Sale$440KJun 26SEC ↗
Sale$144KJun 17SEC ↗
Tsao DavidFirst filing
Sale$2.0MJun 17SEC ↗
Sale$786KJun 11SEC ↗
Sale$339KJun 11SEC ↗
Sale$1.1MJun 11SEC ↗
Atay OguzhanFirst filing
Sale$3.2MJun 11SEC ↗

Related companies

BillionToOne, Inc. is in the Healthcare sector.